DiCART TM Device for Capillary Refill Time Measurement
DICART-VS
2 other identifiers
interventional
20
1 country
1
Brief Summary
To estimate peripheral perfusion in shock state, international guidelines recommend the use of capillary refill time, and practitioners currently evaluates it at bedside. However its measurement is not standardized, what should explain the large observer variability reported in different studies. Hence, a device providing a standardized evaluation seems to be helpful. The aim of the study is to evaluate diagnostic performance of such a device recently developped (DiCART TM), in healthy volunteers experiencing vascular occlusion tests to induce impaired perfusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2020
CompletedFirst Submitted
Initial submission to the registry
August 28, 2020
CompletedFirst Posted
Study publicly available on registry
September 4, 2020
CompletedSeptember 4, 2025
August 1, 2025
5 months
August 28, 2020
August 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Capillary refill time on the thenar eminence evaluated with DiCART TM device.
Diagnostic performance of DiCART TM device to detect a capillary refill time variation on the thenar eminence induced by a vascular occlusion test on the arm. DiCART TM measurement is fully automatized, and may be separated in three consecutive step : * An automatized cutaneous compression * A video acquisition of cutaneous recoloration * Data interpretation The investigators will compute Receptor Operative Characteristics curves with area under the curve, and will determine best threshold and grey zone to evaluate diagnostic performance of DiCART TM device to detect impaired perfusion.
180 minutes
Secondary Outcomes (12)
Capillary refill time evaluated on the knee with DiCART TM device
180 minutes
Intra -observer variability of capillary refill time measurement with DiCART TM device by performing repetitive measurements by two different investigators.
180 minutes
Intra -observer variability of capillary refill time measurement with clinical method by performing repetitive measurements by two different investigators.
180 minutes
Inter-observer variability of capillary refill time measurement with DiCART TM device by performing repetitive measurements by two different investigators.
180 minutes
Inter-observer variability of capillary refill time measurement with clinical method by performing repetitive measurements by two different investigators.
180 minutes
- +7 more secondary outcomes
Study Arms (1)
measure capillary refill time
EXPERIMENTALInterventions
Each time, capillary refill time will be evaluated three times consecutively by clinical method applying a firm pressure with the finger during 15s, then brutally releasing it, and estimating time of skin recoloration with a chronometer and by DiCART TM device Three vascular occlusion tests will be successively performed with a cuff during less than 10 minutes: * Arterial vascular occlusion test (50mmHg above systolic arterial pressure of the healthy volunteers), * Veinous vascular occlusion test (30mmHg), * Control test without vascular occlusion test. Capillary refill time measurements will be repeated just before, during and just after vascular occlusion tests. Randomization determine the order of the vascular occlusion tests. Investigators performing capillary refill time evaluation will be blinded from it. Vascular occlusion tests will be alternatively performed by one and the other limb. The whole protocol will be performed at the upper and then at the lower limb.
Eligibility Criteria
You may qualify if:
- Healthy volunteers
- Age \> 18 years old
- Informed consent to participate
You may not qualify if:
- Vascular disease
- Diabetes mellitus
- Dermatosis
- Cutaneous lesion on a measurement site
- Anemia
- Pregnancy
- Cardiovascular chronic treatment
- Non affiliation to a social security regime
- Involvement in other interventional study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Louis Pradel
Bron, France
Related Publications (1)
Ruste M, Cazenave L, Tardif M, Saint-Jean C, Fellahi JL, Lagreze MJ. Measurement of capillary refill time with a handheld prototype device: a comparative validation study in healthy volunteers. J Clin Monit Comput. 2022 Oct;36(5):1271-1278. doi: 10.1007/s10877-021-00757-2. Epub 2021 Sep 22.
PMID: 34550528RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias JACQUET-LAGREZE, MD
Hospices Civils de Lyon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- the investigators evaluate capillary refill time without knowing the status of vascular occlusion test.
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 28, 2020
First Posted
September 4, 2020
Study Start
January 28, 2020
Primary Completion
July 10, 2020
Study Completion
July 10, 2020
Last Updated
September 4, 2025
Record last verified: 2025-08